In the title compound, C 17 H 27 N 3 O 4 , the six-membered ring adopts a half-chair conformation with the N atom and the adjacent methylene C atom displaced by À0.391 (2) and 0.358 (2) Å , respectively, from the plane of the other four atoms. In the crystal, molecules are linked by weak C-HÁ Á ÁO interactions.
Related literature
For a related structure and background references to heterocycles as pharmaceuticals, see: Guo (2011).
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). -isopropyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c] pyridine-3,5-dicarboxylate H.-M. Guo Comment As part of our ongoing studies of heterocycles (Guo, 2011), herein we report the structure of the title compound.
In the molecule (Fig. 1) , all bond lengths and angles are within normal ranges.The atoms N1, N2, C1, C2, C3, C4 and C6 lie in a plan(p1), with a maximum deviation of 0.0100 (15)Å; atoms N3, C13, O3, O4, and C14 lie in a plan(p2) too, the maximum deviation is 0.0552 (12)Å. The dihedral angle between p1 and p2 is 75.44 (5)°.
The title compound was synthesized with 5-tert-butyl 3-ethyl 6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-3,5(4H)-dicarboxylate (1 eq), NaH (2.5 eq) and 2-bromopropane (1.2 eq) in THF at 273 K to room temperature. Single crystals of the compound suitable for X-ray measurements were obtained by recrystallization from ethanol at room temperature.
Refinement
All H atoms were fixed geometrically and allowed to ride on their attached atoms, with C-H distances in the range 0.98-1.00 Å, and with U iso (H) = 1.2U eq (C) or U iso (H) = 1.5U eq (C methyl ).
Figures Fig. 1 . The molecular structure of the title compound with displacement ellipsoids drawn at the 30% probability level. 
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